Index RUT
P/E -
EPS (ttm) -0.69
Insider Own 32.20%
Shs Outstand 60.35M
Perf Week 0.06%
Market Cap 4.24B
Forward P/E -
EPS next Y -1.96
Insider Trans -14.53%
Shs Float 44.45M
Perf Month 82.85%
Income -32.18M
PEG -
EPS next Q -0.43
Inst Own 69.02%
Short Float 10.67%
Perf Quarter 133.30%
Sales 58.88M
P/S 71.93
EPS this Y -174.80%
Inst Trans 37.60%
Short Ratio 2.09
Perf Half Y 514.07%
Book/sh 5.43
P/B 11.89
EPS next Y -11.44%
ROA -9.63%
Short Interest 4.74M
Perf Year 824.18%
Cash/sh 4.99
P/C 12.94
EPS next 5Y -
ROE -12.69%
52W Range 6.71 - 64.72
Perf YTD 238.93%
Dividend Est. -
P/FCF -
EPS past 5Y 24.56%
ROI -9.55%
52W High -0.19%
Beta 0.87
Dividend TTM -
Quick Ratio 7.86
Sales past 5Y 171.70%
Gross Margin 99.02%
52W Low 862.74%
ATR (14) 1.36
Dividend Ex-Date -
Current Ratio 7.86
EPS Y/Y TTM 58.73%
Oper. Margin -75.16%
RSI (14) 82.74
Volatility 0.18% 2.71%
Employees 142
Debt/Eq 0.03
Sales Y/Y TTM 95.84%
Profit Margin -54.66%
Recom 2.75
Target Price 65.00
Option/Short Yes / Yes
LT Debt/Eq 0.03
EPS Q/Q 124.03%
Payout -
Rel Volume 0.85
Prev Close 64.60
Sales Surprise 238.91%
EPS Surprise 145.45%
Sales Q/Q 1011.42%
Earnings Mar 18 AMC
Avg Volume 2.26M
Price 64.60
SMA20 8.40%
SMA50 40.14%
SMA200 176.22%
Trades
Volume 1,924,182
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-09-24 Initiated
Guggenheim
Buy
$55
Feb-15-24 Initiated
Wolfe Research
Outperform
$44
Oct-18-23 Initiated
Berenberg
Buy
$18
Oct-17-23 Initiated
Berenberg
Buy
$18
Oct-05-23 Initiated
RBC Capital Mkts
Outperform
$19
Jun-26-23 Resumed
Oppenheimer
Outperform
$14
Jan-19-23 Initiated
Morgan Stanley
Overweight
$17
Nov-21-22 Initiated
SVB Leerink
Outperform
$15
Dec-21-20 Initiated
H.C. Wainwright
Buy
$21
Aug-26-20 Initiated
Cowen
Outperform
May-03-24 08:45AM
May-02-24 10:01AM
Apr-25-24 11:28AM
Apr-18-24 08:30AM
Apr-15-24 03:43PM
09:15AM
Loading…
09:15AM
Apr-13-24 05:29AM
Apr-12-24 12:36PM
10:55AM
(The Wall Street Journal)
Apr-11-24 04:43PM
04:29PM
04:18PM
(Investor's Business Daily)
01:59PM
(The Wall Street Journal)
01:07PM
11:58AM
11:03AM
Loading…
11:03AM
09:47AM
09:47AM
09:39AM
07:34AM
Apr-10-24 10:34PM
07:05PM
05:47PM
(The Wall Street Journal)
05:14PM
(Investor's Business Daily)
04:19PM
04:16PM
04:15PM
04:06PM
04:01PM
01:34PM
09:23AM
Loading…
Apr-09-24 09:23AM
Apr-01-24 09:00AM
Mar-21-24 07:45AM
Mar-20-24 04:30PM
Mar-19-24 08:32AM
06:48AM
(Thomson Reuters StreetEvents)
Mar-18-24 08:53PM
07:25PM
05:31PM
04:05PM
Mar-14-24 08:38AM
Mar-11-24 10:00AM
Mar-07-24 04:30PM
Feb-26-24 04:30PM
Feb-01-24 04:30PM
Dec-21-23 04:15PM
Dec-19-23 09:50AM
Dec-18-23 04:30PM
Dec-06-23 09:55AM
Nov-29-23 09:40AM
Nov-20-23 04:30PM
09:55AM
Nov-17-23 07:44PM
Nov-15-23 09:00AM
Nov-14-23 08:55PM
04:15PM
03:57PM
Nov-13-23 09:00AM
Nov-06-23 09:41PM
06:00AM
Nov-03-23 09:00AM
Nov-02-23 09:00AM
Oct-30-23 10:01AM
09:00AM
Oct-27-23 09:40AM
Oct-23-23 12:00PM
Oct-13-23 09:05AM
Oct-12-23 12:13PM
Oct-11-23 10:15AM
Oct-09-23 11:10AM
Oct-06-23 09:55AM
09:24AM
Oct-04-23 08:17AM
08:00AM
Oct-03-23 07:43AM
Sep-18-23 08:52AM
Sep-12-23 08:30AM
Sep-08-23 09:40AM
Sep-05-23 04:30PM
08:30AM
Aug-30-23 04:30PM
Aug-24-23 08:50AM
Aug-22-23 04:30PM
Aug-17-23 09:55AM
Aug-14-23 04:15PM
Jul-23-23 10:25AM
Jun-22-23 07:43AM
Jun-20-23 07:14PM
May-19-23 04:30PM
May-11-23 04:15PM
May-05-23 07:04AM
May-01-23 04:30PM
Mar-27-23 09:16AM
07:08AM
Mar-24-23 10:02AM
(Thomson Reuters StreetEvents) -8.25%
Mar-23-23 05:35PM
04:05PM
Mar-20-23 04:30PM
Mar-16-23 05:30PM
Mar-15-23 04:30PM
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing innovative, protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Topper James N Director Apr 25 '24 Sale 64.57 19 1,227 2,829,347 Apr 29 04:32 PM Rickey James Paul See Remarks Jan 26 '24 Option Exercise 8.30 117,764 977,844 73,764 Jan 29 07:04 PM Rickey James Paul See Remarks Jan 26 '24 Sale 23.32 117,764 2,745,830 0 Jan 29 07:04 PM Rickey James Paul See Remarks Jan 25 '24 Option Exercise 6.51 236 1,536 236 Jan 29 07:04 PM Rickey James Paul See Remarks Jan 25 '24 Sale 22.00 236 5,192 0 Jan 29 07:04 PM GOLD MITCHELL Executive Chairman and CEO Dec 28 '23 Option Exercise 12.74 74,441 948,378 2,675,421 Dec 29 07:32 PM GOLD MITCHELL Executive Chairman and CEO Dec 28 '23 Option Exercise 0.65 1,016 660 1,016 Dec 29 07:32 PM ORBIMED ADVISORS LLC Director Dec 28 '23 Sale 18.35 1,364,849 25,049,034 264,315 Dec 29 04:18 PM Thompson Peter A. Director Dec 28 '23 Sale 18.35 1,364,849 25,049,034 264,315 Dec 29 04:20 PM GOLD MITCHELL Executive Chairman and CEO Dec 28 '23 Sale 20.04 1,016 20,362 0 Dec 29 07:32 PM GOLD MITCHELL Executive Chairman and CEO Dec 27 '23 Option Exercise 0.65 29,573 19,222 29,573 Dec 27 09:07 PM ORBIMED ADVISORS LLC Director Dec 27 '23 Sale 19.96 181,498 3,622,700 406,609 Dec 29 04:18 PM Thompson Peter A. Director Dec 27 '23 Sale 19.96 181,498 3,622,700 406,609 Dec 29 04:20 PM GOLD MITCHELL Executive Chairman and CEO Dec 27 '23 Sale 20.04 29,573 592,717 0 Dec 27 09:07 PM GOLD MITCHELL Executive Chairman and CEO Dec 26 '23 Option Exercise 0.63 24,486 15,436 24,486 Dec 27 09:07 PM GOLD MITCHELL Executive Chairman and CEO Dec 26 '23 Sale 20.22 24,486 495,217 0 Dec 27 09:07 PM GOLD MITCHELL Executive Chairman and CEO Dec 22 '23 Option Exercise 0.45 37,825 17,021 37,825 Dec 27 09:07 PM GOLD MITCHELL Executive Chairman and CEO Dec 22 '23 Sale 20.43 37,825 772,595 0 Dec 27 09:07 PM Rickey James Paul See Remarks Dec 19 '23 Option Exercise 5.02 15,213 76,369 15,213 Dec 21 07:35 PM GOLD MITCHELL Executive Chairman and CEO Dec 19 '23 Option Exercise 0.45 2,402 1,081 2,402 Dec 21 07:34 PM Rickey James Paul See Remarks Dec 19 '23 Sale 19.21 15,213 292,222 0 Dec 21 07:35 PM GOLD MITCHELL Executive Chairman and CEO Dec 19 '23 Sale 20.01 2,402 48,064 0 Dec 21 07:34 PM Rickey James Paul See Remarks Dec 18 '23 Option Exercise 5.02 1,800 9,036 1,800 Dec 18 09:20 PM Rickey James Paul See Remarks Dec 18 '23 Sale 19.00 1,800 34,203 0 Dec 18 09:20 PM Rickey James Paul See Remarks Dec 15 '23 Option Exercise 5.02 45,387 227,843 45,387 Dec 18 09:20 PM Rickey James Paul See Remarks Dec 15 '23 Sale 19.09 45,387 866,383 0 Dec 18 09:20 PM Rickey James Paul See Remarks Dec 14 '23 Option Exercise 5.02 11,600 58,232 11,600 Dec 18 09:20 PM Rickey James Paul See Remarks Dec 14 '23 Sale 19.00 11,600 220,406 0 Dec 18 09:20 PM GOLD MITCHELL Executive Chairman and CEO Dec 12 '23 Option Exercise 0.45 8,613 3,876 8,613 Dec 12 09:02 PM GOLD MITCHELL Executive Chairman and CEO Dec 12 '23 Sale 17.32 41,063 711,026 0 Dec 12 09:02 PM GOLD MITCHELL Executive Chairman and CEO Dec 11 '23 Sale 17.26 68,870 1,189,027 32,450 Dec 12 09:02 PM GOLD MITCHELL Executive Chairman and CEO Dec 08 '23 Sale 17.08 8,067 137,784 101,320 Dec 12 09:02 PM Rickey James Paul See Remarks Dec 06 '23 Option Exercise 3.23 6,446 20,821 6,446 Dec 06 07:31 PM Rickey James Paul See Remarks Dec 06 '23 Sale 16.08 6,446 103,650 0 Dec 06 07:31 PM Rickey James Paul See Remarks Dec 05 '23 Option Exercise 3.23 418 1,350 418 Dec 06 07:31 PM Rickey James Paul See Remarks Dec 05 '23 Sale 16.01 418 6,694 0 Dec 06 07:31 PM Rickey James Paul See Remarks Dec 04 '23 Option Exercise 3.23 63,947 206,549 63,947 Dec 06 07:31 PM Rickey James Paul See Remarks Dec 04 '23 Sale 16.06 63,947 1,026,887 0 Dec 06 07:31 PM Rickey James Paul See Remarks Nov 30 '23 Option Exercise 3.23 700 2,261 700 Dec 01 05:00 PM Rickey James Paul See Remarks Nov 30 '23 Sale 16.00 700 11,200 0 Dec 01 05:00 PM Rickey James Paul See Remarks Nov 06 '23 Option Exercise 3.23 10,989 35,494 18,003 Nov 08 05:20 PM Rickey James Paul See Remarks Nov 06 '23 Sale 16.03 18,003 288,554 0 Nov 08 05:20 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite